ELOVL6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.81120000000801E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.31070000000777E-06 |
Normal-vs-Stage2 |
2.226900E-04 |
Normal-vs-Stage3 |
1.97428999999527E-05 |
Normal-vs-Stage4 |
5.60530000000004E-05 |
Stage1-vs-Stage2 |
4.262200E-01 |
Stage1-vs-Stage3 |
9.534400E-01 |
Stage1-vs-Stage4 |
5.497400E-01 |
Stage2-vs-Stage3 |
5.668400E-01 |
Stage2-vs-Stage4 |
8.294000E-01 |
Stage3-vs-Stage4 |
6.384600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.51810000004193E-06 |
Normal-vs-AfricanAmerican |
3.384400E-03 |
Normal-vs-Asian |
3.446400E-01 |
Caucasian-vs-AfricanAmerican |
3.422500E-02 |
Caucasian-vs-Asian |
5.221200E-01 |
AfricanAmerican-vs-Asian |
8.348000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.31870000053792E-07 |
Normal-vs-Female |
7.98820000000866E-05 |
Male-vs-Female |
3.553600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.04250000024331E-07 |
Normal-vs-Age(41-60Yrs) |
6.05879999948655E-07 |
Normal-vs-Age(61-80Yrs) |
2.37549999999587E-05 |
Normal-vs-Age(81-100Yrs) |
2.654800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.614800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.975860E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.004400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.315700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.490300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.372440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.144800E-03 |
Normal-vs-Grade 2 |
2.34769999996054E-06 |
Normal-vs-Grade 3 |
1.39929999998234E-06 |
Normal-vs-Grade 4 |
6.787900E-04 |
Grade 1-vs-Grade 2 |
6.676000E-01 |
Grade 1-vs-Grade 3 |
5.834000E-01 |
Grade 1-vs-Grade 4 |
7.056400E-01 |
Grade 2-vs-Grade 3 |
7.493600E-01 |
Grade 2-vs-Grade 4 |
8.752300E-02 |
Grade 3-vs-Grade 4 |
5.299800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.50109999985659E-07 |
Normal-vs-ccB subtype |
2.954700E-04 |
ccA subtype-vs-ccB subtype |
2.044200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.41259999999422E-05 |
Normal-vs-N1 |
7.263000E-03 |
N0-vs-N1 |
3.065400E-01 |
|
|